**Core Concept**
The question is testing the knowledge of NK receptor antagonists, specifically their role in preventing vomiting. NK receptors are a subtype of tachykinin receptors that play a crucial role in the emetic response, which is the body's response to vomiting.

**Why the Correct Answer is Right**
NK receptor antagonists work by blocking the action of substance P, a neurotransmitter that stimulates the vomiting center in the brain. By preventing substance P from binding to NK receptors, these antagonists can effectively prevent vomiting. This mechanism is particularly useful in the treatment of chemotherapy-induced nausea and vomiting (CINV).

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because NK receptor antagonists are not the primary treatment for vomiting.
**Option B:** This option is incorrect because NK receptor antagonists do not work by blocking dopamine receptors.
**Option C:** This option is incorrect because NK receptor antagonists are not the primary treatment for motion sickness.

**Clinical Pearl / High-Yield Fact**
NK receptor antagonists, such as aprepitant, are often used in combination with other antiemetics to provide effective protection against CINV. This combination is known as a "triple therapy" approach.

**Correct Answer: D. Aprepitant**